ES446700A1 - Biphenyl derivatives and pharmaceutical compositions thereof - Google Patents

Biphenyl derivatives and pharmaceutical compositions thereof

Info

Publication number
ES446700A1
ES446700A1 ES446700A ES446700A ES446700A1 ES 446700 A1 ES446700 A1 ES 446700A1 ES 446700 A ES446700 A ES 446700A ES 446700 A ES446700 A ES 446700A ES 446700 A1 ES446700 A1 ES 446700A1
Authority
ES
Spain
Prior art keywords
general formula
compound
group
hydroxy group
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES446700A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES446700A1 publication Critical patent/ES446700A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Procedure for the preparation of new biphenyl derivatives of the general formula I, ** (See formula) ** wherein the radical represents a chlorine or fluorine atom and B represents the hydroxy group, an alkoxy or aralkoxy group or the amino group and, if B means the hydroxy group, of its salts with organic and inorganic bases, characterized because for the preparation of compounds of the general formula I, in which B represents a hydroxy group, an alkoxy or aralkoxy group, a compound of the general formula II is reacted, ** (See formula) ** where R1 is as defined above and Hal means a halogen atom, with a compound of the general formula, ** (See formula) ** wherein the radical means an alcoholic or aralcohyl group, first to form a compound of the general formula ** (See formula) ** wherein R1 and R2 have the meanings indicated above, by heating in an anhydrous inert solvent, and then the resulting compound of the general formula III is heated with a strong base, after acidification a compound of the general formula I is isolated, in that B means the hydroxy group, or is heated with water, forming a compound of the general formula I, in which B has the meaning of an alkoxy or aralkoxy radical, depending on which of these meanings had the radical R7 in the compound of general formula III; and the eventually obtained racemates are split by fractional crystallization of their salts with optically active bases into their two individual optically active components and, if desired, compounds of the general formula I obtained, in which B means the alkoxy group, are saponified to forming compounds of the general formula I, in which B represents the hydroxy group, and, if desired, compounds of the general formula I obtained in which B is the hydroxy group, are transformed, according to usual methods, into their esters or in their salts by organic or inorganic bases or, if desired, for the preparation of compounds of the general formula I, in which B means the amino radical, a compound of the general formula I is reacted, where B represents an alkoxy group or a halogen atom, with ammonia at elevated temperatures. (Machine-translation by Google Translate, not legally binding)
ES446700A 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof Expired ES446700A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732341507 DE2341507A1 (en) 1973-08-16 1973-08-16 NEW BIPHENYL DERIVATIVES AND METHOD OF MANUFACTURING

Publications (1)

Publication Number Publication Date
ES446700A1 true ES446700A1 (en) 1977-06-01

Family

ID=5889963

Family Applications (11)

Application Number Title Priority Date Filing Date
ES446698A Expired ES446698A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446692A Expired ES446692A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446694A Expired ES446694A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446695A Expired ES446695A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446693A Expired ES446693A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446689A Expired ES446689A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446690A Expired ES446690A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES76446691A Expired ES446691A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446701A Expired ES446701A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446700A Expired ES446700A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446699A Expired ES446699A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof

Family Applications Before (9)

Application Number Title Priority Date Filing Date
ES446698A Expired ES446698A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446692A Expired ES446692A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446694A Expired ES446694A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446695A Expired ES446695A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446693A Expired ES446693A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446689A Expired ES446689A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446690A Expired ES446690A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES76446691A Expired ES446691A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof
ES446701A Expired ES446701A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES446699A Expired ES446699A1 (en) 1973-08-16 1976-04-03 Biphenyl derivatives and pharmaceutical compositions thereof

Country Status (18)

Country Link
JP (1) JPS5049262A (en)
AT (1) AT331235B (en)
AU (1) AU7243074A (en)
BE (1) BE818952A (en)
DD (1) DD114590A5 (en)
DE (1) DE2341507A1 (en)
DK (1) DK433674A (en)
ES (11) ES446698A1 (en)
FI (1) FI238974A (en)
FR (1) FR2240722B1 (en)
GB (1) GB1445283A (en)
HU (1) HU168875B (en)
IL (1) IL45464A0 (en)
NL (1) NL7410292A (en)
NO (1) NO742802L (en)
RO (1) RO72842A (en)
SE (1) SE7410436L (en)
ZA (1) ZA745257B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0231257A1 (en) * 1985-07-12 1987-08-12 The Upjohn Company Chemical compounds comrpising substituted phenylrings
US6100260A (en) * 1997-04-21 2000-08-08 Sumitomo Pharmaceutical Company, Limited Isoxazole derivatives
EP0979226B1 (en) * 1997-04-21 2005-11-09 Sumitomo Pharmaceuticals Company, Limited Isoxazole derivatives
US9206143B2 (en) * 2008-03-19 2015-12-08 Aurimmed Pharma, Inc. Compounds advantageous in the treatment of central nervous system diseases and disorders
US9212155B2 (en) 2008-03-19 2015-12-15 Aurimmed Pharma, Inc. Compounds advantageous in the treatment of central nervous system diseases and disorders
US10793515B2 (en) 2008-03-19 2020-10-06 Aurimmed Pharma, Inc. Compounds advantageous in the treatment of central nervous system diseases and disorders

Also Published As

Publication number Publication date
DE2341507A1 (en) 1975-02-27
ES446691A1 (en) 1977-06-16
FR2240722A1 (en) 1975-03-14
BE818952A (en) 1975-02-17
NL7410292A (en) 1975-02-18
ES446694A1 (en) 1977-06-16
FR2240722B1 (en) 1978-07-28
ES446689A1 (en) 1977-06-16
ES446701A1 (en) 1977-06-01
ZA745257B (en) 1976-04-28
ES446692A1 (en) 1977-06-16
IL45464A0 (en) 1974-11-29
HU168875B (en) 1976-07-28
GB1445283A (en) 1976-08-11
AT331235B (en) 1976-08-10
DK433674A (en) 1975-04-28
ES446690A1 (en) 1977-07-01
ES446698A1 (en) 1977-06-16
ATA577674A (en) 1975-11-15
AU7243074A (en) 1976-02-19
FI238974A (en) 1975-02-17
ES446693A1 (en) 1977-06-16
DD114590A5 (en) 1975-08-12
ES446695A1 (en) 1977-07-01
RO72842A (en) 1981-11-04
NO742802L (en) 1975-03-17
JPS5049262A (en) 1975-05-01
SE7410436L (en) 1975-02-17
ES446699A1 (en) 1977-06-16

Similar Documents

Publication Publication Date Title
ES391299A1 (en) 2-(n-allyl-phenylamino)-imidazolines-(2)and salts thereof
ES446700A1 (en) Biphenyl derivatives and pharmaceutical compositions thereof
ES390895A1 (en) Esters of phenylalanine
ES390163A1 (en) Procedure for the preparation of amino-derivatives of pirazolo (3,4-b) pyridine-5-carboxylic acids. (Machine-translation by Google Translate, not legally binding)
ES419739A1 (en) 2-aryl-amino-imidazoline-2 compounds
ES378202A1 (en) 2-(imidazolid inylidence-(2)-amino)-5-nitro-thiazoles and salts thereof
ES432465A1 (en) Substituted 4-biphenylyl-butenoic acids esters and amides and pharmaceutical compositions containing them
ES412068A1 (en) Xylidides
ES432476A1 (en) Procedure for the preparation of new derivatives of bifenilo. (Machine-translation by Google Translate, not legally binding)
ES406768A1 (en) Procedure for the preparation of new indol derivatives. (Machine-translation by Google Translate, not legally binding)
ES406367A1 (en) Thiazolino-pyrimidin-5-one derivatives, process for their preparation and applications thereof
ES419195A1 (en) Benzoisoindoline derivatives
ES432474A1 (en) Procedure for the preparation of new derivatives of bifenilo. (Machine-translation by Google Translate, not legally binding)
ES417792A1 (en) Procedure for the preparation of new derivatives of bifenilo. (Machine-translation by Google Translate, not legally binding)
ES415904A1 (en) Procedure for the obtaining of 1- (dialgnilfenil-fe-milpiridil-) - methyl - inidazoles. (Machine-translation by Google Translate, not legally binding)
ES432469A1 (en) Procedure for the preparation of new derivatives of bifenilo. (Machine-translation by Google Translate, not legally binding)
ES402483A1 (en) Substituted tetrahydroquinolines
ES426553A1 (en) Procedure for preparing 2-formilquinoxalina-1.4-godosox. (Machine-translation by Google Translate, not legally binding)
ES432467A1 (en) Procedure for the preparation of new derivatives of bifenilo. (Machine-translation by Google Translate, not legally binding)
ES432471A1 (en) Procedure for the preparation of new derivatives of bifenilo. (Machine-translation by Google Translate, not legally binding)
ES390235A1 (en) Process for the production of 6-amino-penicillanic acid derivatives
ES394944A1 (en) A procedure for the preparation of 2- (6-metoxy2-nafthy) propionic acid and 2- (6-metoxy-2-nafthyl) -1- propanol. (Machine-translation by Google Translate, not legally binding)
ES432466A1 (en) Procedure for the preparation of new derivatives of bifenilo. (Machine-translation by Google Translate, not legally binding)
ES402551A1 (en) A procedure for the preparation of piperazine derivatives. (Machine-translation by Google Translate, not legally binding)
ES432475A1 (en) Procedure for the preparation of new derivatives of bifenilo. (Machine-translation by Google Translate, not legally binding)